Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Article (1)
- COVID-19 (1)
- Clinical article (1)
- Drug bioavailability (1)
- Drug cost (1)
-
- Epidemiology (1)
- Exploratory research (1)
- Female (1)
- Folic acid (1)
- Health care personnel (1)
- Health insurance (1)
- Hepatitis C (1)
- Human (1)
- Human development (1)
- Human immunodeficiency virus (1)
- Hydroxychloroquine (1)
- Immunosuppressants (1)
- Male (1)
- Maximum permissible dose (1)
- Medical education (1)
- Medical practice (1)
- Medication compliance (1)
- Methotrexate (1)
- Nephritis (1)
- Patient compliance (1)
- Patient education (1)
- Perception (1)
- Prednisone (1)
- Prescription (1)
- Prevalence (1)
Articles 1 - 4 of 4
Full-Text Articles in Rheumatology
Short Term Outcomes Of Covid-19 In Lupus: Propensity Score Matched Analysis From A Nationwide Multi-Centric Research Network, Rahul Raiker, Haig Pakhchanian, Charles Deyoung, Latika Gupta, Sinan Kardes, Sakir Ahmed, Chengappa Kavadichanda
Short Term Outcomes Of Covid-19 In Lupus: Propensity Score Matched Analysis From A Nationwide Multi-Centric Research Network, Rahul Raiker, Haig Pakhchanian, Charles Deyoung, Latika Gupta, Sinan Kardes, Sakir Ahmed, Chengappa Kavadichanda
Student Papers, Posters & Projects
Objectives
To determine the severity and outcome of COVID-19 among individuals with lupus as compared to controls. The secondary objective was to identify the risk association of sex, race, presence of nephritis, and use of various immunomodulators with COVID-19 outcomes.
Methods
Retrospective data of individuals with lupus with and without COVID-19 between January 2020 to May 2021 was retrieved from the TriNetX. A one-to-one matched COVID-19 positive control was selected using propensity score(PS) matching. We assessed several outcomes, including all-cause mortality, hospitalisation, intensive care unit (ICU) admission, mechanical ventilation, severe COVID, acute kidney injury (AKI), Haemodialysis, acute respiratory distress syndrome …
Outcomes Of Covid-19 In Patients With Rheumatoid Arthritis: A Multicenter Research Network Study In The United States., Rahul Raiker, Charles Deyoung, Haig Pakhchanian, Sakir Ahmed, Chengappa Kavadichanda, Latika Gupta, Sinan Kardeş
Outcomes Of Covid-19 In Patients With Rheumatoid Arthritis: A Multicenter Research Network Study In The United States., Rahul Raiker, Charles Deyoung, Haig Pakhchanian, Sakir Ahmed, Chengappa Kavadichanda, Latika Gupta, Sinan Kardeş
Student Papers, Posters & Projects
OBJECTIVES: To investigate outcomes of Coronavirus Disease-2019 (COVID-19) in patients with rheumatoid arthritis (RA) as compared to the general population. Additionally, outcomes were explored among RA patients stratified by sex, race, and medications use through sub-cohort analyses.
METHODS: This comparative cohort study used a US multicenter research network (TriNetX) to extract data on all adult RA patients who were diagnosed with COVID-19, and adults without RA who were diagnosed with COVID-19 (comparative cohort) anytime from January 20, 2020 to April 11, 2021. COVID-19 outcomes were assessed within 30 days after its diagnosis. Baseline characteristics that included demographics and comorbidities were …
Perceptions And Challenges Experienced By African Physicians When Prescribing Methotrexate For Rheumatic Disease: An Exploratory Study, Carol A Hitchon, Girsh M Mody, Candace H Feldman, Yan Lau, Steven Shi, Michele Meltzer, Rosie Scuccimarri, Michael E Weinblatt, Ines Colmegna
Perceptions And Challenges Experienced By African Physicians When Prescribing Methotrexate For Rheumatic Disease: An Exploratory Study, Carol A Hitchon, Girsh M Mody, Candace H Feldman, Yan Lau, Steven Shi, Michele Meltzer, Rosie Scuccimarri, Michael E Weinblatt, Ines Colmegna
Department of Medicine Faculty Papers
Objective: Guidelines for methotrexate (MTX) use in rheumatic disease may not be feasible for physicians practicing in the least developed countries. We aimed to understand the experiences of MTX prescribers relating to MTX use for rheumatic disease in African countries to inform the development of culturally and geographically appropriate recommendations.
Methods: African physicians who self-identified as MTX prescribers from countries classified as having a low versus a medium or high Human Development Index (L-HDI versus MH-HDI) participated in semistructured interviews between August 2016 and September 2017. Interviews were transcribed verbatim, coded thematically, and stratified by HDI.
Results: Physicians (23 rheumatologists; …
Perceptions And Challenges Experienced By African Physicians When Prescribing Methotrexate For Rheumatic Disease: An Exploratory Study, Carol A Hitchon, Girsh M Mody, Candace H Feldman, Yan Lau, Steven Shi, Michele Meltzer, Rosie Scuccimarri, Michael E Weinblatt, Ines Colmegna
Perceptions And Challenges Experienced By African Physicians When Prescribing Methotrexate For Rheumatic Disease: An Exploratory Study, Carol A Hitchon, Girsh M Mody, Candace H Feldman, Yan Lau, Steven Shi, Michele Meltzer, Rosie Scuccimarri, Michael E Weinblatt, Ines Colmegna
Department of Medicine Faculty Papers
OBJECTIVE: Guidelines for methotrexate (MTX) use in rheumatic disease may not be feasible for physicians practicing in the least developed countries. We aimed to understand the experiences of MTX prescribers relating to MTX use for rheumatic disease in African countries to inform the development of culturally and geographically appropriate recommendations.
METHODS: African physicians who self-identified as MTX prescribers from countries classified as having a low versus a medium or high Human Development Index (L-HDI versus MH-HDI) participated in semistructured interviews between August 2016 and September 2017. Interviews were transcribed verbatim, coded thematically, and stratified by HDI.
RESULTS: Physicians (23 rheumatologists; …